Helsinn
Helsinn is a subsidiary of global pharmaceutical company Helsinn.
Helsinn is a privately owned, self-financing pharmaceutical group with headquarters in Lugano, Switzerland and premises in Ireland and USA. The Helsinn Group has been built on the basis of a unique business model, focused on the in- and out-licensing of pharmaceuticals, with the recent additions of medical devices in therapeutic niche areas.
Financial Data
-
31st Dec 17 Source: CRO
- €168.2 million turnover
-
€14.8 million
profit - 182 employees
-
31st Dec 16 Source: CRO
- €245.1 million turnover
-
€80.2 million
profit - 177 employees
- 6 more years available »
Ranking
By Turnover
(€168.2 million)- 350th in Top Companies
- 39th in Pharma
By Employees
(182)- 588th in Top Companies
- 56th in Pharma
-
- 182
- €168.2 million
Employees
- Padraig Somers CEO/Managing Director
Latest News
- 12:10pm Deutsche Bank to transfer up to 800 staff to BNP
- 10:06am Star Capital acquires wind turbine installation contractor Windhoist
- 9:42am European shares grind higher ahead of Powell speech
- 9:26am Pilot grounded by easyJet after telling friends he was suicidal
- 8:34am Shares in Peppa Pig owner jump 30% after Hasbro’s $4bn bid